Analytical Data
-
基因名
ZYG11B
- Application
-
别名
Protein zyg-11 homolog B
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9C0D3
-
表达区间
1-390 aa
-
氨基酸序列
MEKTKPEILKLVVTGMRNHPMNLPVQLAASACVFNLTKQDLAAGMPVRLLADVTHLLLKAMEHFPNHQQLQKNCLLSLCSDRILQDVPFNRFEAAKLVMQWLCNHEDQNMQRMAVAIISILAAKLSTEQTAQLGTELFIVRQLLQIVKQKTNQNSVDTTLKFTLSALWNLTDESPTTCRHFIENQGLELFMRVLESFPTESSIQQKVLGLLNNIAEVQELHSELMWKDFIDHISSLLHSVEVEVSYFAAGIIAHLISRGEQAWTLSRSQRNSLLDDLHSAILKWPTPECEMVAYRSFNPFFPLLGCFTTPGVQLWAVWAMQHVCSKNPSRYCSMLIEEGGLQHLYNIKDHEHTDPHVQQIAVAILDSLEKHIVRHGRPPPCKKQPQARLN
-
分子量
68.64 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ZYG11B, a member of the ZYG11 protein family, has garnered significant attention in the field of molecular biology and biomedicine due to its crucial role in cell cycle regulation and tumorigenesis. Initially identified as a gene involved in the cell division process, ZYG11B is believed to participate in the degradation of key regulatory proteins, thereby influencing mitotic progression and maintaining genomic stability. Dysregulation of ZYG11B expression has been linked to various cancers, suggesting its potential as a biomarker for tumor initiation and progression. Recent studies have focused on the recombinant expression of ZYG11B to elucidate its structure-function relationships and provide insights into its mechanisms of action. This pursuit includes the production of ZYG11B recombinant proteins for functional assays, aiding in the identification of interaction partners and downstream signaling pathways. Understanding the implications of ZYG11B in cellular processes could unveil novel therapeutic strategies for cancer treatment. As researchers continue to explore the intricacies of this protein, the development of ZYG11B-targeted interventions holds promise for improving cancer outcomes and advancing precision medicine.












